EP.12A.03 Overall Survival after Treatment with First-Line Osimertinib for EGFR-Mutant Advanced NSCLC in the US.
| Autor: | Sabari, J.K., Yu, H.A., Mahadevia, P., Liu, Y., Demirdjian, L., Sultan, A.A., Chen, Y.H., Wang, X., Passaro, A. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS619-S620, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|